Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study).
Authors
Aranda, E.; Manzano, J. L.; Rivera, F.; Galán, M.; Valladares-Ayerbes, M.; Pericay, C.; Safont, M. J.; Mendez, M. J.; Irigoyen, A.; Arrivi, A.; Sastre, J.; Díaz-Rubio, E.